Loss of expression of oestrogen receptor β in colon cancer and its association with Dukes' staging

N. Jassam, S. M. Bell, Valerie Speirs*, P. Quirke

*Corresponding author for this work

Research output: Contribution to journalArticle

104 Citations (Scopus)

Abstract

Gender differences in the incidence and behaviour of colon cancer suggest a hormonal influence and epidemiological data suggest a protective effect for hormone replacement therapy. Recently it has been shown that oestrogen receptor (ER) β is the predominant ER in colon tissue. The aim of this study was to examine the expression and distribution of ERβ in normal and colorectal cancer samples, using immunohistochemistry and (in a subset of patients) real-time quantitative reverse transcriptase polymerase chain reaction in a well-defined patient cohort and to correlate this with clinico-pathological outcome. Immunohistochemical analyses of normal colon revealed strong specific nuclear immunoreactivity in all epithelial cells lining the colonic crypts. In colon cancer, ERβ expression was lost in 21% of samples irrespective of patient age or gender. Interestingly loss of ERβ expression was higher in left colon and rectal cancers (27%) compared to right colon cancers (8%). A correlation between loss of ERβ expression and advanced Dukes stage was observed. Loss of ERβ with increased Dukes' stage suggests that it may be affording a protective effect against colon carcinogenesis. Its presence may be a favourable prognostic marker in this disease and could explain the protective effect of oestrogens against colon cancer development.

Original languageEnglish
Pages (from-to)17-21
Number of pages5
JournalOncology Reports
Volume14
Issue number1
Publication statusPublished - Jul 2005

Fingerprint

Estrogen Receptors
Colonic Neoplasms
Colon
Hormone Replacement Therapy
Rectal Neoplasms
Reverse Transcriptase Polymerase Chain Reaction
Colorectal Neoplasms
Estrogens
Carcinogenesis
Epithelial Cells
Immunohistochemistry
Incidence

Keywords

  • Colon cancer
  • Oestrogen receptor β

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Loss of expression of oestrogen receptor β in colon cancer and its association with Dukes' staging. / Jassam, N.; Bell, S. M.; Speirs, Valerie; Quirke, P.

In: Oncology Reports, Vol. 14, No. 1, 07.2005, p. 17-21.

Research output: Contribution to journalArticle

@article{c2ac602a578949f889a19be70af61875,
title = "Loss of expression of oestrogen receptor β in colon cancer and its association with Dukes' staging",
abstract = "Gender differences in the incidence and behaviour of colon cancer suggest a hormonal influence and epidemiological data suggest a protective effect for hormone replacement therapy. Recently it has been shown that oestrogen receptor (ER) β is the predominant ER in colon tissue. The aim of this study was to examine the expression and distribution of ERβ in normal and colorectal cancer samples, using immunohistochemistry and (in a subset of patients) real-time quantitative reverse transcriptase polymerase chain reaction in a well-defined patient cohort and to correlate this with clinico-pathological outcome. Immunohistochemical analyses of normal colon revealed strong specific nuclear immunoreactivity in all epithelial cells lining the colonic crypts. In colon cancer, ERβ expression was lost in 21{\%} of samples irrespective of patient age or gender. Interestingly loss of ERβ expression was higher in left colon and rectal cancers (27{\%}) compared to right colon cancers (8{\%}). A correlation between loss of ERβ expression and advanced Dukes stage was observed. Loss of ERβ with increased Dukes' stage suggests that it may be affording a protective effect against colon carcinogenesis. Its presence may be a favourable prognostic marker in this disease and could explain the protective effect of oestrogens against colon cancer development.",
keywords = "Colon cancer, Oestrogen receptor β",
author = "N. Jassam and Bell, {S. M.} and Valerie Speirs and P. Quirke",
year = "2005",
month = "7",
language = "English",
volume = "14",
pages = "17--21",
journal = "Oncology Reports",
issn = "1021-335X",
publisher = "Spandidos Publications",
number = "1",

}

TY - JOUR

T1 - Loss of expression of oestrogen receptor β in colon cancer and its association with Dukes' staging

AU - Jassam, N.

AU - Bell, S. M.

AU - Speirs, Valerie

AU - Quirke, P.

PY - 2005/7

Y1 - 2005/7

N2 - Gender differences in the incidence and behaviour of colon cancer suggest a hormonal influence and epidemiological data suggest a protective effect for hormone replacement therapy. Recently it has been shown that oestrogen receptor (ER) β is the predominant ER in colon tissue. The aim of this study was to examine the expression and distribution of ERβ in normal and colorectal cancer samples, using immunohistochemistry and (in a subset of patients) real-time quantitative reverse transcriptase polymerase chain reaction in a well-defined patient cohort and to correlate this with clinico-pathological outcome. Immunohistochemical analyses of normal colon revealed strong specific nuclear immunoreactivity in all epithelial cells lining the colonic crypts. In colon cancer, ERβ expression was lost in 21% of samples irrespective of patient age or gender. Interestingly loss of ERβ expression was higher in left colon and rectal cancers (27%) compared to right colon cancers (8%). A correlation between loss of ERβ expression and advanced Dukes stage was observed. Loss of ERβ with increased Dukes' stage suggests that it may be affording a protective effect against colon carcinogenesis. Its presence may be a favourable prognostic marker in this disease and could explain the protective effect of oestrogens against colon cancer development.

AB - Gender differences in the incidence and behaviour of colon cancer suggest a hormonal influence and epidemiological data suggest a protective effect for hormone replacement therapy. Recently it has been shown that oestrogen receptor (ER) β is the predominant ER in colon tissue. The aim of this study was to examine the expression and distribution of ERβ in normal and colorectal cancer samples, using immunohistochemistry and (in a subset of patients) real-time quantitative reverse transcriptase polymerase chain reaction in a well-defined patient cohort and to correlate this with clinico-pathological outcome. Immunohistochemical analyses of normal colon revealed strong specific nuclear immunoreactivity in all epithelial cells lining the colonic crypts. In colon cancer, ERβ expression was lost in 21% of samples irrespective of patient age or gender. Interestingly loss of ERβ expression was higher in left colon and rectal cancers (27%) compared to right colon cancers (8%). A correlation between loss of ERβ expression and advanced Dukes stage was observed. Loss of ERβ with increased Dukes' stage suggests that it may be affording a protective effect against colon carcinogenesis. Its presence may be a favourable prognostic marker in this disease and could explain the protective effect of oestrogens against colon cancer development.

KW - Colon cancer

KW - Oestrogen receptor β

UR - http://www.scopus.com/inward/record.url?scp=24644454427&partnerID=8YFLogxK

M3 - Article

VL - 14

SP - 17

EP - 21

JO - Oncology Reports

JF - Oncology Reports

SN - 1021-335X

IS - 1

ER -